A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Choroidal MelanomaIndeterminate Lesions of Eye
Trial Locations (16)

10032

RECRUITING

Columbia University Medical Center, New York

19107

RECRUITING

Wills Eye Hospital, Philadelphia

29605

RECRUITING

Retina Consultants of Carolina, PA, Greenville

37203

RECRUITING

St. Thomas Health / Tennessee Retina, PC, Nashville

48073

RECRUITING

Associated Retinal Consultants, PC, Royal Oak

48105

RECRUITING

W. K. Kellogg Eye Center, University of Michigan, Ann Arbor

53705

RECRUITING

University of Wisconsin, Madison

55404

RECRUITING

Retina Center, Minneapolis

75231

RECRUITING

Texas Retina Associates, Dallas

77030

RECRUITING

Retina Consultants of Houston, Houston

85710

RECRUITING

Retina Associates SW, P.C., Tucson

90095

RECRUITING

UCLA Jules Stein Eye Institute, Los Angeles

94303

RECRUITING

Byers Eye Institute at Stanford University, Palo Alto

95825

ACTIVE_NOT_RECRUITING

Retina Consultants of Sacramento, Sacramento

97239

RECRUITING

Oregon Health & Science University Casey Eye Institute, Portland

02114

RECRUITING

Massachusetts Eye and Ear Infirmary, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aura Biosciences

INDUSTRY

NCT03941379 - A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma | Biotech Hunter | Biotech Hunter